CC · Chemours Co
One customer — 7% of receivables (December 31, 2025)
“At December 31, 2025, one individual customer balance represented approximately 7% of our total outstanding accounts and notes receivable balance.”
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $5.8B | $5.81B | $5.78B | $6.08B | $6.83B | $6.35B | $4.97B | $5.53B | $6.64B | $6.18B | $5.4B | $5.72B | $6.43B | $6.86B | |
| — | — | — | — | — | — | — | -$208M | -$195M | -$214M | -$219M | -$132M | — | — | |
| $4.91B | $4.91B | $4.64B | $4.78B | $5.22B | $4.96B | $3.9B | $4.46B | $4.67B | $4.44B | $4.3B | $4.76B | $5.07B | $5.4B | |
| $886M | $902M | $1.14B | $1.3B | $1.62B | $1.38B | $1.07B | $1.06B | $1.97B | $1.75B | $1.1B | $955M | $1.36B | $1.46B | |
| — | 15.53% | 19.75% | 21.42% | 23.66% | 21.77% | 21.47% | 19.24% | 29.69% | 28.22% | 20.43% | 16.7% | 21.14% | 21.34% | |
| $106M | $108M | $109M | $108M | $118M | $107M | $93M | $80M | $82M | $81M | $81M | $97M | $143M | $164M | |
| $868M | $799M | $598M | $1.29B | $710M | $592M | $527M | $548M | $657M | $626M | $946M | $632M | $685M | $768M | |
| — | $1M | $1M | $10M | $5M | — | — | — | — | — | — | — | — | — | |
| $320M | $340M | $292M | $309M | $291M | $317M | $320M | $311M | $284M | $273M | $284M | $267M | $257M | $261M | |
| — | — | — | — | — | $12M | $20M | $44M | $45M | $24M | $4M | $137M | $16M | — | |
| $998M | $966M | $823M | $1.55B | $844M | $705M | $700M | $715M | $788M | $764M | $1.2B | $1.09B | $849M | — | |
| $926M | — | — | — | — | — | — | — | — | — | — | $1.09B | $849M | $934M | |
| $273M | $269M | $263M | $208M | $163M | $185M | $210M | $208M | $195M | $214M | $219M | $132M | $0 | $0 | |
| $314M | $26M | $8M | $91M | $70M | $163M | $21M | -$293M | $162M | $113M | $267M | $54M | $19M | — | |
| $35M | $35M | $43M | $45M | $55M | $43M | $23M | $29M | $43M | $33M | $29M | $22M | $20M | $22M | |
| -$52M | -$277M | $106M | -$318M | $741M | $676M | $179M | -$124M | $1.16B | $912M | -$11M | -$188M | $550M | $576M | |
| $253M | $109M | $37M | -$66M | $163M | $68M | -$40M | -$72M | $159M | $165M | -$18M | -$98M | $149M | $152M | |
| -$304M | -$386M | $69M | -$253M | $578M | $608M | $219M | -$52M | $995M | $746M | $7M | -$90M | $400M | $423M | |
| — | -6.65% | 1.19% | -4.16% | 8.46% | 9.58% | 4.41% | -0.94% | 14.99% | 12.07% | 0.13% | -1.57% | 6.22% | 6.17% | |
| — | — | — | $1M | — | — | $0 | $0 | $1M | $1M | $0 | $0 | $1M | $1M | |
| -$247M | -$263M | -$24M | -$184M | $599M | $554M | $258M | $163M | $873M | $881M | -$34M | -$334M | $400M | $423M | |
| USD/shares | -$2.00 | -$2.57 | $0.46 | -$1.70 | $3.72 | $3.69 | $1.33 | -$0.32 | $5.62 | $4.04 | $0.04 | -$0.50 | $2.21 | $2.34 |
| USD/shares | -$2.00 | -$2.57 | $0.46 | -$1.70 | $3.65 | $3.60 | $1.32 | -$0.32 | $5.45 | $3.91 | $0.04 | -$0.50 | $2.21 | $2.34 |
| shares | — | 150.24M | 149.49M | 148.91M | 155.36M | 164.94M | 164.68M | 164.82M | 176.97M | 184.84M | 181.62M | 180.99M | 180.97M | 180.97M |
| shares | — | 150.24M | 150.17M | 148.91M | 158.3M | 168.7M | 166.35M | 164.82M | 182.57M | 190.98M | 183.42M | 180.99M | 180.97M | 180.97M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2025: $1.81B in buybacks, $1.32B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 37 similar-size Specialty Chemicals companies (of 63 listed).
EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Titanium Technologies | $2,429,000,000 | $2,572,000,000 | $2,680,000,000 | $3,380,000,000 | $3,355,000,000 | $2,402,000,000 | $2,345,000,000 | $3,174,000,000 |
| Thermal and Specialized Solutions | $2,066,000,000 | $1,830,000,000 | $1,851,000,000 | $1,702,000,000 | $1,257,000,000 | $1,105,000,000 | $1,318,000,000 | $1,497,000,000 |
| Advanced Performance Materials | $1,263,000,000 | $1,326,000,000 | $1,462,000,000 | $1,633,000,000 | $1,397,000,000 | $1,104,000,000 | $1,330,000,000 | $1,365,000,000 |
| Other Non-Reportable Segment | $50,000,000 | $54,000,000 | — | — | — | — | — | — |
| Chemical Solutions | — | — | — | — | — | — | $533,000,000 | $602,000,000 |
| All Other Segments | — | — | $85,000,000 | $116,000,000 | $336,000,000 | $358,000,000 | — | — |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| North America | $2,654,000,000 | $2,589,000,000 | $2,745,000,000 | $2,984,000,000 | $2,317,000,000 | $1,914,000,000 | $2,144,000,000 | $2,378,000,000 |
| Asia Pacific | $1,243,000,000 | $1,386,000,000 | $1,462,000,000 | $1,787,000,000 | $1,827,000,000 | $1,384,000,000 | $1,543,000,000 | $1,720,000,000 |
| EMEA | $1,163,000,000 | $1,138,000,000 | $1,197,000,000 | $1,315,000,000 | $1,412,000,000 | $1,086,000,000 | $1,163,000,000 | $1,685,000,000 |
| Latin America | $748,000,000 | $669,000,000 | $674,000,000 | $745,000,000 | $789,000,000 | $585,000,000 | $676,000,000 | $855,000,000 |
By Product & Service (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| SPS Capstone | $88,000,000 | $97,000,000 | $104,000,000 | — | — | — |
| Fluorochemicals | — | — | — | $1,318,000,000 | $1,497,000,000 | $1,378,000,000 |
| Fluoropolymers | — | — | — | $1,330,000,000 | $1,365,000,000 | $1,276,000,000 |
| Mining Solutions | — | — | — | $268,000,000 | $289,000,000 | $261,000,000 |
| Performance Chemicals and Intermediates | — | — | — | $265,000,000 | $313,000,000 | $306,000,000 |
| Titanium Dioxide and Other Minerals | — | — | — | $2,345,000,000 | $3,174,000,000 | $2,958,000,000 |